How McKinsey used its FDA connections to help opioid manufacturers: New congressional report

Following reports that McKinsey engaged in abusive and deceptive business practices to stoke the flames of the opioid epidemic, the House Oversight committee on Wednesday released a new report documenting how the consulting company leveraged its work with the FDA to drive new business with opioid manufacturers.